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Atherosclerosis and insulin resistance are globally prevalent metabolic diseases, primarily 
driven by endothelial and hepatic inflammation, respectively. High density lipoprotein (HDL) 
reduces the inflammation in models of atherosclerosis and insulin sensitivity, and in doing so, 
improves these conditions. Our laboratory has demonstrated that in human coronary artery 
endothelial cells (HCAECs), HDL’s suppression of the inflammatory response is a gene-
regulated process and that 3 -hydroxysteroid- 24 reductase (DHCR24) is one of the most 
upregulated genes by HDL.  
DHCR24 is a cholesterol biosynthesis enzyme however, recent work in various cell types shows 
DHCR24 emerging as a potent multifaceted protein protecting against cellular stress. This 
study commenced with confirming apolipoprotein I (apoA-I) rHDL increases DHCR24 
expression in HCAECs, while revealing for the first time that HDL also increases DHCR24 
expression in human hepatoma 7 (HuH7) cells. 
This study next questioned whether DHCR24 mimics apoA-I rHDL’s suppression of the 
inflammatory response in these cell types. The data presented provides proof-of-principle that 
DHCR24 replicates HDL’s suppression of tumour necrosis factor-alpha (TNF- )-induced 
intracellular cell adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-
1) levels in HCAECs, and interleukin 8 (IL-8) levels in HuH7 cells. 
Characterising DHCR24’s role was explored to learn more about how DHCR24 suppresses a 
TNF- -induced inflammatory response in HCAECs and HuH7 cells. This study showed that 
DHCR24’s oxidoreductase region mediates DHCR24’s suppression of a TNF- -induced 
inflammatory response in these cell types. This effect occurred without DHCR24 increasing 
cholesterol levels, despite the oxidoreductase site’s integral role in cholesterol biosynthesis. 
These are exciting results as they indicate that DHCR24 is more than just a cholesterol 
biosynthesis enzyme in HCAECs and HuH7 cells.  
Elucidating the mechanisms by which DHCR24 suppresses a TNF- -induced inflammatory 
response in HCAECs and HuH7 cells highlighted a cell type-specific nature of DHCR24’s activity, 
which is in keeping with reports in the literature. In keeping with this cell type-specificity, a 
TNF- -induced inflammatory response was suppressed, in part, by a decreased endoplasmic 
reticulum (ER) stress response in HCAECs. Interestingly, this did not occur in HuH7 cells. The 




compared to HCAECs. DHCR24’s cell type-specific effects are reinforced by the cellular 
response of DHCR24 levels to TNF- -activation – in HCAECs, DHCR24 levels were modestly 
increased; conversely in HuH7 cells, TNF- -activation markedly decreased DHCR24 levels. 
Moreover, TNF- -activation caused DHCR24’s translocation from its ER-localisation to the 
cytoplasm and nucleus, while in HuH7 cells, DHCR24 remained localised peri-nuclearly.  
This data provides novel mechanistic insight into DHCR24’s multifunctional role in two 
different cell types, laying the foundation for potential DHCR24-based therapeutics, and 
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